<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>31349</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-2172-2-2</infon><infon key="article-id_pmc">31349</infon><infon key="article-id_pmid">11316463</infon><infon key="article-id_publisher-id">1471-2172-2-2</infon><infon key="fpage">2</infon><infon key="journal-title">BMC Immunology</infon><infon key="lpage">2</infon><infon key="name_0">surname:Vidal-Rubio;given-names:Berta</infon><infon key="name_1">surname:Sanchez-Carril;given-names:Marta</infon><infon key="name_2">surname:Oliver-Morales;given-names:Josefina</infon><infon key="name_3">surname:Gonz&#225;lez-Femandez;given-names:&#193;frica</infon><infon key="name_4">surname:Gamb&#243;n-Deza;given-names:Francisco</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2</infon><infon key="year">2001</infon><offset>0</offset><text>Changes in human lymphocyte subpopulations in tonsils and regional lymph nodes of human head and neck squamous carcinoma compared to control lymph nodes</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>153</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>164</offset><text>Lymphoid tissues are the basic structures that enable immune responses to occur, leading to the development of germinal centres (GCs), cell migration, and memory cells. We have compared human tumour reactive lymph nodes and tonsils to control lymphnodes in this study.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>460</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>468</offset><text>According to the flow cytometry analysis, most cells in control lymph nodes were naive T-lymphocytes (CD45RA+/CD7+), while in reactive noses the percentage of CD45RO+ T cells was unchanged, and the number of B-LYmphoblastic cells increased and their percentage decreased. In both cases, the proportion of cells expressing CD69 was similar in reacting node as well as controls; two populations of T cell-element-negative for CD68 or CD66dull are either either positive for this combination.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1057</offset><text>The use of confocal microscopy to analyze tissue sections revealed discrepancies between control, tonsils and tumor reactive lymph nodes. In control lymphnodes, CD19 B cells are surrounded by a distinct layer of CD69bright/CD45RO+ T cells. GCs from tonsil and tumour reactive node are predominantly composed of these CDIN- B cell types, with four distinct layers in each cavity. The central zone is made up of CDR9-B cells encircled by CD66bD69BL NGN2 cells und the outer zones of</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1617</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1629</offset><text>In human secondary lymphoid organs, there are an increase in B lymphocytes and a decrease in CD45RA+ T cell (naive) numbers. This response is caused by chronic pathogen stimulation in tonsils, while in lymph nodes draining head and neck carcinomas the reaction is triggered by surrounded tumors. During this process, secondary glandular lymphatic tissues develop secondary follicles with alternating amounts of T and B cells, which are then deposited into each layer by microscope intervals through confosilicular structures that may serve as arbitrary functions.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2243</offset><text>Tonsils are a small blood vessel found in the upper part of the neck. They are the most important source of blood for the brain, heart, lungs and pancreas. They are also the most frequently affected organ in the world. The majority of patients with tonsillar cancer have a very small tumor. The tumor is usually within the lymph nodes or can be found on the surface of the tonsils, which are a very thin, bloodless skin.

Tonsil tumors are particularly difficult to find on a tumour scan. They are found in many different locations in the body, and with the exception of the brain, are more difficult to track down because of the low number of tumors that can be found. The most common</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2254</offset><text>T-dependent immune responses in which T, B and antigen-presenting cells interact at the secondary lymphoid organs are defined by specific factors: a healthy T cell population is located primarily in the paracortical zone (including the interfollicular areas), while B cells are placed in small primary fojicles inthe cortex, which become secondary folicle(s) or germinal centres (GCs.)</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2642</offset><text>Recent research has shown that the GC reaction can occur through or without interleukin and is mediated by both cellular contacts and humoral factors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3842</offset><text>Due to a lack of information about the origin, migration, and function of intra-GC T cells in human follicles, it is challenging to investigate the GC reaction kinetics in humans. This study compares control lymph nodes with human tonsils and tumour reactive lymphnodes from patients with head and neck's carcinomas.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4148</offset><text>By examining various membrane antigens and markers, it was determined that the identification and distribution of cells in these nodes was achieved best. These markers included CD69, an early activation antig&#232;ne, CD45RA, a marker mostly associated with virgin cells, and CD44OG, which was mostly linked to memory cells. Additionally, the distribution between control and reactive lymph node was observed, with varying degrees of B and T cells detected in different layers of tissue sections.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4650</offset><text>A speculative model of the cellular traffic into the general capillary chain reaction (GC) is presented, and these results suggest that T cells play a key role in regulation of this chemical cycle.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4804</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>4812</offset><text>Decrease of CD45RA+ T cells in tonsils and tumour reactive lymph nodes</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4883</offset><text>Lymphoid subpopulations from human control lymph nodes, tonsils and tumour reactive lymph nodes have been compared. Flow cytometry was used to analyse a total of 28 control lymph nodes, 9 tonsils and 65 head and neck tumour reactive lymph nodes. In all cases several markers were used (Table 1). These included markers related to specific T or B cells, others, like CD69, to the activation level and, finally, CD45RA naive or CD45RO memory, which are associated with the state of maturation.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>5375</offset><text>Lymphocyte subpopulations from control lymph nodes, tonsils and reactive lymph nodes to head and neck carcinoma</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;Control&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;lymph&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="left" colspan="3"&gt;&lt;bold&gt;&lt;italic&gt;Reactive lymph nodes to lead&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;nodes&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Tonsils&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="left" colspan="3"&gt;&lt;bold&gt;&lt;italic&gt;and neck carcinoma&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;&lt;italic&gt;ANTIGEN&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;Mean&lt;/italic&gt; &#177;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;Mean&lt;/italic&gt;&lt;/bold&gt; &#177;&lt;/td&gt;&lt;td align="left"&gt;&lt;bold&gt;&lt;italic&gt;P&lt;sup&gt;a)&lt;/sup&gt; (Tonsil&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;P&lt;sup&gt;a)&lt;/sup&gt;(reactive&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;SD&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;SD&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;Vs control)&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Mean &#177; SD&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;&lt;italic&gt;Vs control)&lt;/italic&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD7&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;27&lt;/td&gt;&lt;td align="center"&gt;68 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;48 &#177; 11&lt;/td&gt;&lt;td align="center"&gt;0.0002&lt;/td&gt;&lt;td align="center"&gt;62&lt;/td&gt;&lt;td align="center"&gt;62 &#177; 11&lt;/td&gt;&lt;td align="center"&gt;0.01&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD19&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;26&lt;/td&gt;&lt;td align="center"&gt;24 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;40 &#177; 15&lt;/td&gt;&lt;td align="center"&gt;0.004&lt;/td&gt;&lt;td align="center"&gt;63&lt;/td&gt;&lt;td align="center"&gt;30 &#177; 11&lt;/td&gt;&lt;td align="center"&gt;0.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD4&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;26&lt;/td&gt;&lt;td align="center"&gt;58 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;42 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;0.0005&lt;/td&gt;&lt;td align="center"&gt;65&lt;/td&gt;&lt;td align="center"&gt;56 &#177; 12&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD8&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;27&lt;/td&gt;&lt;td align="center"&gt;12 &#177; 5&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;8 &#177; 1&lt;/td&gt;&lt;td align="center"&gt;0.002&lt;/td&gt;&lt;td align="center"&gt;65&lt;/td&gt;&lt;td align="center"&gt;9 &#177; 4&lt;/td&gt;&lt;td align="center"&gt;0.03&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD45RA&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;28&lt;/td&gt;&lt;td align="center"&gt;63 &#177; 9&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;54 &#177; 17&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;td align="center"&gt;64&lt;/td&gt;&lt;td align="center"&gt;58 &#177; 12&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD45RO&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;28&lt;/td&gt;&lt;td align="center"&gt;29 &#177; 8&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;31 &#177; 9&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;td align="center"&gt;63&lt;/td&gt;&lt;td align="center"&gt;33 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD7/CD45RA&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;25&lt;/td&gt;&lt;td align="center"&gt;37 &#177; 14&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;16 &#177; 4&lt;/td&gt;&lt;td align="center"&gt;0.0004&lt;/td&gt;&lt;td align="center"&gt;60&lt;/td&gt;&lt;td align="center"&gt;29 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;0.004&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD7/CD45RO&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;26&lt;/td&gt;&lt;td align="center"&gt;24 &#177; 8&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;27 &#177; 9&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;td align="center"&gt;60&lt;/td&gt;&lt;td align="center"&gt;28 &#177; 8&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD69&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;td align="center"&gt;14 &#177; 12&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;29 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;0.02&lt;/td&gt;&lt;td align="center"&gt;14&lt;/td&gt;&lt;td align="center"&gt;23 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD3/CD69&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;12 &#177; 11&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;21 &#177; 10&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;td align="center"&gt;14&lt;/td&gt;&lt;td align="center"&gt;19 &#177; 8&lt;/td&gt;&lt;td align="center"&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>5487</offset><text>	Control	lymph				Reactive lymph nodes to lead	 		nodes		Tonsils			and neck carcinoma	 	ANTIGEN	N	Mean &#177;	N	Mean &#177;	Pa) (Tonsil	N		Pa)(reactive	 			SD		SD	Vs control)		Mean &#177; SD	Vs control)	 		 	CD7	27	68 &#177; 10	9	48 &#177; 11	0.0002	62	62 &#177; 11	0.01	 	CD19	26	24 &#177; 10	9	40 &#177; 15	0.004	63	30 &#177; 11	0.05	 	CD4	26	58 &#177; 10	9	42 &#177; 10	0.0005	65	56 &#177; 12	NS	 	CD8	27	12 &#177; 5	9	8 &#177; 1	0.002	65	9 &#177; 4	0.03	 	CD45RA	28	63 &#177; 9	9	54 &#177; 17	NS	64	58 &#177; 12	NS	 	CD45RO	28	29 &#177; 8	9	31 &#177; 9	NS	63	33 &#177; 10	NS	 	CD7/CD45RA	25	37 &#177; 14	9	16 &#177; 4	0.0004	60	29 &#177; 10	0.004	 	CD7/CD45RO	26	24 &#177; 8	9	27 &#177; 9	NS	60	28 &#177; 8	NS	 	CD69	8	14 &#177; 12	9	29 &#177; 10	0.02	14	23 &#177; 10	NS	 	CD3/CD69	7	12 &#177; 11	9	21 &#177; 10	NS	14	19 &#177; 8	NS	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>6195</offset><text>a) P &lt; 0.05 by Kruskal-Wallis test considered significant. NS means no significant.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6279</offset><text>The results show that T cells are the main population in all groups analysed. However, there is a decrease in the number of T cells, both CD4 and CD8 lymphocytes, in tumour reactive lymph nodes and in tonsils, compared to controls (Table 1). To study the expression of the molecule CD45, double immunofluorescence was used. Both the CD45RA isoform, associated to the naive phenotype, and the CD45RO-related to the memory phenotype were analysed. This revealed a decrease in the percentage of CD7+/CD45RA+ in tonsils and in tumour reactive lymph nodes compared to controls (Figure 1). No percentual change was detected in the expression of CD45RO within tonsils and nodes. However, an increase in the percentage of B cells in tonsils and in tumour reactive lymph nodes, was observed in comparison with control lymph nodes.</text></passage><passage><infon key="file">1471-2172-2-2-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7101</offset><text>Two color analysis of lymphocytes from human control lymph nodes (A), tonsils (B) and reactive lymph nodes to head and neck carcinoma (C). Cells were stained with anti-CD45RA-FITC and anti-CD7-PE monoclonal antibodies.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7320</offset><text>The analysis of CD69, described as an early activation marker, indicates that it is expressed in a fraction of lymphocytes in all lymph nodes analysed (Table 1). Although slightly higher in tonsil B cells, there are no significant differences in the expression of CD69 between reactive and control lymph nodes. The differences in the intensity of this marker are worth noting. CD69bright is expressed in a fraction of T cells, but B cells are mainly CD69- or dull (Figure 2).</text></passage><passage><infon key="file">1471-2172-2-2-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7796</offset><text>Expression of antigen CD69 in human lymphocytes from control lymph nodes (A), tonsils (B) and reactive lymph nodes to head and neck carcinoma (C). Cells were stained with anti-CD3-FITC and anti-CD69-PE monoclonal antibodies.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8021</offset><text>Histological distribution of lymphoid subpopulations in control lymph nodes, tonsils and head and neck tumour reactive lymph nodes</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8152</offset><text>As described in Materials and Methods tissue sections were analysed by confocal microscopy. Subpopulations of cells with specific monoclonal antibodies against different membrane molecules were identified. Nuclear staining was performed with 7-AAD (in blue). As was expected, in control lymph nodes there are mainly primary follicles constituted by accumulations of B-lymphocytes surrounded by T cells. However, GCs appear in both, tumour reactive lymph nodes and tonsils. By confocal microscopy, B cells in control lymph nodes were mainly CD19dull. This contrasted with GC B-lymphocytes from tonsils and tumour reactive lymph nodes that expressed on their membrane higher levels of the CD19 antigen (Figure 3). Although other causes cannot be completely rule out, the variations found in the fluorescence intensity of the marker CD19 could be due to the larger size of the GC-B cells</text></passage><passage><infon key="file">1471-2172-2-2-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>9037</offset><text>Distribution of T (CD7+) and B cells (CD19+) in frozen sections from human control lymph node, tonsil and reactive lymph node to head and neck carcinoma. Sections were stained with anti-CD7- PE and anti-CD19-FITC monoclonal antibodies and with 7 AAD and analyzed by confocal microscopy. F: primary follicle; GC: germinal center; M: mantle of B cells; C: centrogerminal layer of T cells.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9424</offset><text>In tonsils and in tumour reactive lymph nodes, secondary follicles or GCs showed a particular lymphocyte distribution in four layers. From the internal to the outer part of the GC, layers of B / T / B and, finally, again T-lymphocytes can be seen. Although some CD7+ T cells are also present (Figure 3), the internal layer is formed mainly by CD19+ B cells. It is possible to see a thin layer of CD7+ T cells as a crown of cells, surrounding these B cells (C in Figure 3). The third layer, external to these T cells, is constituted by small B-lymphocytes, which form the follicular mantle region. Among these follicular mantle B cells there are some CD7+ T cells located in a radial disposition. The final layer is formed by CD7+ T-lymphocytes that spread to the interfollicular zones. Despite the lower number of secondary follicles found in tumour reactive lymph nodes as compared to those in tonsils, both showed the same distribution in layers of T and B cells (Figure 3).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10401</offset><text>The tissue location of cells expressing the CD69 antigen (in red) together with two T cell markers, CD3 or CD45RO (both in green), are shown in Figures 4 and 5 respectively. The images obtained from tonsils and tumour reactive lymph nodes reveal that the T cell layer in the GC located under the mantle (C in Figures 4 and 5), is CD3+/CD45RO+/CD69bright. However, follicular mantle B cells are weakly positive for CD69 staining (CD69dull). Scattered T-lymphocytes CD3+/CD45RO+ with a variable expression of CD69 antigen appear in the mantle zone: cells near the T cell layer (region C in Figures 4 and 5) are CD69dull, while those close to the outer zone of the mantle are CD69 - (fig 5). Very few CD69+ cells were found in the interfollicular T zones.</text></passage><passage><infon key="file">1471-2172-2-2-4.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>11154</offset><text>Comparison of the distribution of activated and memory T cells in frozen sections from human control lymph node and tonsil. Sections were stained with 7 AAD, anti-CD69-PE and with anti-CD3-FITC monoclonal antibodies. F: primary follicle; GC: germinal centre; M: mantle of B cells; C: centrogerminal layer of T cells.</text></passage><passage><infon key="file">1471-2172-2-2-5.jpg</infon><infon key="id">F5</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>11471</offset><text>Distribution of activated and memory T cells in frozen sections from human reactive lymph node to head and neck carcinoma. Sections were stained with 7 AAD, anti-CD69-PE and with anti-CD45RO-FITC monoclonal antibodies. F: primary follicle; GC: germinal centre; M: mantle of B cells; C: centrogerminal layer of T cells.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11790</offset><text>In control lymph nodes it is possible to find some CD3+/CD45RO+/CD69+ cells in a discrete and defined area around B cells in the primary follicle. Follicular B cells appear weakly positive to CD69, similar to what is found in the secondary follicle mantle B cells.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>12055</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12066</offset><text>The quantitative and histological changes, at the cellular level, that take place in human secondary lymphoid tissues are described in this paper. These result from either chronic stimulation by pathogens in tonsils, or by tumour stimulation in the draining lymph nodes of human head and neck squamous carcinomas. An increase in the percentage of B-lymphocytes in these organs compared to control lymph nodes, due to the generation of GCs after antigen stimulation, was observed by flow cytometry. In tissue sections, the phenotype and morphology of the primary follicle B cells, in control lymph nodes, were seen to be similar to the secondary follicle mantle B cells in tumor reactive lymph nodes or in tonsils. Several authors consider that after the stimulation, during the immune response, the human B cells placed outside the follicles, in the T cell areas, migrate to the region of B cells and FDCs that form the primary follicle. The stimulated B cells proliferate giving rise to centroblasts, which push the naive B cells to the periphery of the GC, thus generating the follicular mantle.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13164</offset><text>Regarding the T cell population, the most significant data is the decrease of naive T-lymphocytes (CD45RA+) in reactive lymph nodes. Previous studies in other species have demonstrated that naive circulating lymphocytes (L-selectin+) penetrate in the lymph node by the blood vessels and go out by efferent lymphatics. This decrease in naive T cells could be due to a change of phenotype (from CD45RA+ naive T-lymphocytes to CD45RO+memory cells) or to the dilution of this population due to the higher number of reactive lymph node cells. In addition, it has been described that memory cells are retained more often in the sites were antigen is present. In fact, our studies in tissue sections show an increase of CD45RO+ cells compared to control lymph nodes. These CD45RO+ cells are located mainly in two zones: 1) between the follicular mantle and the light zone of the GC and 2) surrounding the secondary follicle.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14082</offset><text>Surprisingly, in the three types of tissues studied, CD69 antigen was only highly expressed in a T-lymphocyte fraction, while B-lymphocytes showed either a negative or a low expression. CD69 has been reported to be an early activation marker, therefore its presence was expected only in reactive lymph nodes and tonsils but not in controls. The study by confocal microscopy confirmed the flow cytometry results. CD69dull B cell population is constituted by cells that form the primary follicles in control lymph nodes and also the GC follicular mantle in reactive lymph nodes and tonsils. It has been described that neither primary follicle B cells nor follicular mantle B cells proliferate during the immune response. This could imply that both have the same origin. The small increase in the CD69 expression found in tonsils, by flow cytometry analysis, is probably due to the greater number of GCs in this tissue, which obviously provokes an increase in the number of mantle cells.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15067</offset><text>CD69bright T-lymphocytes surround B-lymphocytes in primary follicles and are in close contact with the internal part of the CD19/CD69dull mantle B cells in the secondary follicles. This suggests an unknown functional association between these CD69 positive T-lymphocytes and mantle B cells. As the CD69 ligand is still unknown, it is possible to speculate that this molecule could be involved in interactions between these two lymphocyte subpopulations.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15521</offset><text>By confocal microscopy, GCs in tonsils and in tumour reactive lymph nodes can be seen with a distribution of cells in several layers: a CD19bright B cell zone, a CD69bright/CD45RO+ intra-GC T cell layer, a follicular mantle B cell layer and an external T cell zone. A group of T-lymphocytes CD3+/CD69bright/CD45RO+ is organized between the light zone of the GC and the follicular mantle, as a crown of cells. Their phenotype supports findings reported by other authors in mice. Moreover, it is similar to the narrow T cell layer that surrounds the primary follicles in human control lymph nodes (Figure 4). It seems possible that these T cells (CD3+/CD69bright/CD45RO+), already observed in the primary follicle, could give place to the GC T cells when an immune response is initiated.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16307</offset><text>This distribution in a four layer-structure of different lymphoid populations (B / T / B / T cells), indicates a very organized structure. From our results and with data from several authors, a speculative model of migration and activation of lymphocytes in the GCs is suggested (Figure 6). Some authors support the hypothesis that T-B interaction takes place in the area that surrounds the primary follicle and that, later, stimulated B and T cells migrate to the follicle, where they proliferate, forming the GCs. In the inner part of the GC, these CD69bright/CD45RO+ T-lymphocytes could be generated by T-B cellular interaction, migrating to the marginal zone of GC, in close contact with the mantle (Figures 4 and 5). In this model, it is proposed that proliferating memory T cells could continuously be exported to the CD45RO+ layer that surrounds the secondary follicle and that follicular mantle B-lymphocytes could participate in this migration. The CD69 molecule might participate in this process. Moreover, scattered memory T-lymphocytes were found among mantle B cells. The expression of CD69 varies in these T-lymphocytes, it diminishes moving out from the internal part of the GC and it is lacking in cells located near to the outside of the follicle. It is likely that these GC T-lymphocytes could interact with mantle B cells, and also could express all the necessary molecules to be able to interact with B-lymphocytes. Interactions with mantle B cells may provoke an exit of T cells to the mantle outer zone. This may avoid continuous GC T-lymphocyte generation and expansion, which would lead to an unregulated or exacerbated immune response. T cells would join the physiological barrier created by mantle B cells and stop the immune response, keeping a resting memory T-lymphocyte store outside the follicle.</text></passage><passage><infon key="file">1471-2172-2-2-6.jpg</infon><infon key="id">F6</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>18135</offset><text>Proposed model of T cell migration during the development of a secondary follicle. A. primary follicle. The CD7+/CD45RO+/CD69bright are disposed surrounding the primary follicle. B. After antigenic challenge the CD7+/CD45RO+/CD69bright cells migrate into the follicle, where they proliferate. C. The T cells originated into the germinal centre migrate out of the secondary follicle. The expression of CD69 diminishes going out from the internal part of the GC and it is lacking in cells outside of the follicle.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18647</offset><text>To confirm some of these hypotheses, experiments are currently being carried out in our laboratory. These include the study of whether the memory T lymphocytes from the outer layer are progeny of the lymphocytes placed in the inner layers.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>18887</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>18899</offset><text>T lymphocytes are more abundant in human control lymph nodes than in tonsils or tumor reactive lymphnodes. These cells are predominantly T cells with CD45RA+, while primary lymph follicles only exhibit an increase in B cell numbers and a decrease in CD44+ TLLs. Our study suggests that secondary lymphoid flakes are the result of different layers of tissue structures: CD19bright Bcell zone, CD69bRIGHT CD553+ intra- GC T cell layer, lateral T</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>19748</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>19770</offset><text>Tumour reactive lymph nodes</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>19798</offset><text>We have analysed 65 lymph nodes from 44 patients suffering from head and neck squamous carcinomas, with ages ranging between 30 to 65 years. Nodes from patients treated with radiotherapy or chemotherapy were not included in this study. Enlarged reactive lymph nodes were selected randomly from the region draining the area of the tumour and surgically excised. One to three nodes were obtained from each patient.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>20211</offset><text>Control lymph nodes</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>20231</offset><text>The study of truly non-reactive nodes is limited by ethical and practical considerations. Therefore, cystic nodes from patients undergoing surgery for cholelithiasis were taken. Neck lymph nodes were also taken from patients suffering from a thyroid pathology. Inflammatory or tumoral pathologies were excluded. We consider that these nodes represent the closest approximation to normality that can be achieved in a study of this type. Nineteen patients aged between 25- 65 years were studied.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>20725</offset><text>Tonsils</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>20733</offset><text>Nine tonsils were obtained from surgical operations on patients suffering from recurrent tonsillitis. The patients were between 8 and 38 years of age.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>20884</offset><text>Cell preparations</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>20902</offset><text>Single cell suspensions of lymphoid cells were prepared by pressing each lymph node through a stainless steel mesh. The suspensions were placed in cold medium (RPMI 1640) supplemented with 2% FCS and 0.02% sodium azide.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>21122</offset><text>Monoclonal Antibody Staining</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>21151</offset><text>FITC or PE-conjugated monoclonal antibodies were purchased from Coulter, Immunotech and Boehringer Ingelheim. Details of the panel antibodies used are given in Table 2. The staining technique involved direct two-colour immunofluorescence. A million cells were incubated 45 min at 4&#176;C with optimal amounts of FITC and PE-conjugated mAb, washed twice (RPMI 2% FCS) and resuspended in medium. Samples were fixed by adding 200 &#956;l of 0.1% paraformaldehyde solution in PBS to the cellular suspension.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>21648</offset><text>Monoclonal antibodies used</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Official name&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;&lt;bold&gt;Clone&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;&lt;bold&gt;Population recognized&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD3&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;UCHT1&lt;/td&gt;&lt;td align="left"&gt;T cell lineage&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD4&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;T4&lt;/td&gt;&lt;td align="left"&gt;Helper/ inducer T cells&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD7&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;3A1&lt;/td&gt;&lt;td align="left"&gt;T cell lineage&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD8&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;T8&lt;/td&gt;&lt;td align="left"&gt;Cytotoxic T cells&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD19&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;B4&lt;/td&gt;&lt;td align="left"&gt;B cells&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD25&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;1HT44H3&lt;/td&gt;&lt;td align="left"&gt;Activated T and B cells&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD45RA&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;ALB 11&lt;/td&gt;&lt;td align="left"&gt;B and T cell subset&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD45RO&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;UCHL1&lt;/td&gt;&lt;td align="left"&gt;T cell subset&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;CD69&lt;/bold&gt;&lt;/td&gt;&lt;td align="left"&gt;CH/4&lt;/td&gt;&lt;td align="left"&gt;Activated T and B cells&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>21675</offset><text>Official name	Clone	Population recognized	 	CD3	UCHT1	T cell lineage	 	CD4	T4	Helper/ inducer T cells	 	CD7	3A1	T cell lineage	 	CD8	T8	Cytotoxic T cells	 	CD19	B4	B cells	 	CD25	1HT44H3	Activated T and B cells	 	CD45RA	ALB 11	B and T cell subset	 	CD45RO	UCHL1	T cell subset	 	CD69	CH/4	Activated T and B cells	 	</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>21990</offset><text>Flow-cytometric Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>22015</offset><text>An ELITE flow cytometer (Coulter Electronics, Hialeah, FL) equipped with an argon ion laser (488 nm) was used. Lymphocytes were gated using forward and orthogonal light scatter, and the percentage of positive cells for each marker was measured. A minimum of 5,000 cells was analysed for each sample.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>22315</offset><text>Data Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>22329</offset><text>The lymph nodes were classified as control tonsils or reactive nodes to head and neck carcinoma. The control lymph nodes were cystic nodes and neck nodes from patients with non-inflammatory pathologies. The results obtained by flow cytometry were statistically analysed with the SPSS program. The standard error of the mean was determined for each group of nodes. The non-parametric Kruskal-Wallis test was used to assess the statistical significance. This test was chosen because of the difficulty to discern the normal distribution of our data due to the number of samples analyzed.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>22914</offset><text>Tissue sections</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>22930</offset><text>Frozen tissue sections of secondary lymphoid organs were fixed in acetone. The staining technique involved three-colour direct immunofluorescence. FITC and PE-conjugated monoclonal antibodies were from Coulter, Immunotech and Boehringer Ingelheim, and 7-aminoactinomycin D (7AAD) was from Sigma. To avoid unspecific binding the sections with RPMI+2.5% FCS were incubated for 30 minutes. The sections were washed with PBS and incubated 2 hours in a humid chamber in the dark with enough amounts of antibodies and the 7AAD (1 &#956;g/ml) to cover the tissue. Samples were washed twice with PBS and then prepared with Mounting Medium (Inova Diagnostics Inc.). The sections were maintained at 4&#176;C until analysed.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>23636</offset><text>Histological study with confocal microscopy</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>23680</offset><text>Three-colour signals were collected separately on a BioRad MRC-1024-ES confocal system equipped with a krypton/argon ion laser (property of C.A.C.T.I., Vigo University). Photomicrographs were taken from electronic overlays.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title_1</infon><offset>23904</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>23918</offset><text>7AAD, 7- aminoactinomycin D; CD40L, CD40 ligand; FDC, follicular dendritic cell; GC, germinal center.</text></passage><passage><infon key="fpage">225</infon><infon key="lpage">230</infon><infon key="name_0">surname:Kosco-Vilbois;given-names:MH</infon><infon key="name_1">surname:Zentgraft;given-names:H</infon><infon key="name_2">surname:Gerdes;given-names:J</infon><infon key="name_3">surname:Bonnefoy;given-names:JY</infon><infon key="pub-id_doi">10.1016/S0167-5699(97)01048-7</infon><infon key="pub-id_pmid">9153954</infon><infon key="section_type">REF</infon><infon key="source">Immunol Today</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">1997</infon><offset>24020</offset><text>To 'B' or not to 'B' a germinal center?</text></passage><passage><infon key="fpage">107</infon><infon key="lpage">111</infon><infon key="name_0">surname:Kelsoe;given-names:G</infon><infon key="pub-id_pmid">8624801</infon><infon key="section_type">REF</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">1996</infon><offset>24060</offset><text>Life and death in germinal centers (redux).</text></passage><passage><infon key="fpage">832</infon><infon key="lpage">840</infon><infon key="name_0">surname:Thorbecke;given-names:GJ</infon><infon key="name_1">surname:Amin;given-names:AR</infon><infon key="name_2">surname:Tsiagbe;given-names:VK</infon><infon key="pub-id_pmid">8070632</infon><infon key="section_type">REF</infon><infon key="source">FASEB J</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">1994</infon><offset>24104</offset><text>Biology of germinal centers in lymphoid tissue.</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">44</infon><infon key="name_0">surname:Casamayor-Palleja;given-names:M</infon><infon key="name_1">surname:Gulbranson-Judge;given-names:A</infon><infon key="name_2">surname:MacLennan;given-names:ICM</infon><infon key="section_type">REF</infon><infon key="source">In Human B cell populations Edited by Ferrarini M and Caligaris-Cappio F Basel, Karger: Chem Immunol</infon><infon key="type">ref</infon><infon key="year">1997</infon><offset>24152</offset><text>T cells in the selection of germinal center B cells.</text></passage><passage><infon key="fpage">173</infon><infon key="lpage">179</infon><infon key="name_0">surname:Secord;given-names:EA</infon><infon key="name_1">surname:Rizzo;given-names:LV</infon><infon key="name_2">surname:Barroso;given-names:EWS</infon><infon key="name_3">surname:Umetsu;given-names:DT</infon><infon key="name_4">surname:Thorbecke;given-names:GJ</infon><infon key="name_5">surname:DeKruyff;given-names:RH</infon><infon key="pub-id_doi">10.1006/cimm.1996.0307</infon><infon key="pub-id_pmid">8954617</infon><infon key="section_type">REF</infon><infon key="source">Cell Immunol</infon><infon key="type">ref</infon><infon key="volume">174</infon><infon key="year">1996</infon><offset>24205</offset><text>Reconstitution of germinal center formation in nude mice with Th1 and Th2 clones.</text></passage><passage><infon key="fpage">3023</infon><infon key="lpage">3029</infon><infon key="name_0">surname:Vyth-Dreese;given-names:FA</infon><infon key="name_1">surname:Dellemijn;given-names:TAM</infon><infon key="name_2">surname:Majoor;given-names:D</infon><infon key="name_3">surname:de Jong;given-names:D</infon><infon key="pub-id_pmid">7489738</infon><infon key="section_type">REF</infon><infon key="source">Eur J Immunol</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">1995</infon><offset>24287</offset><text>Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.</text></passage><passage><infon key="fpage">111</infon><infon key="lpage">126</infon><infon key="name_0">surname:Liu;given-names:YJ</infon><infon key="name_1">surname:Arpin;given-names:C</infon><infon key="pub-id_pmid">9280752</infon><infon key="section_type">REF</infon><infon key="source">Immunol Rev</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="year">1997</infon><offset>24408</offset><text>Germinal center development.</text></passage><passage><infon key="fpage">256</infon><infon key="lpage">262</infon><infon key="name_0">surname:Liu;given-names:YJ</infon><infon key="name_1">surname:de Bouteiller;given-names:O</infon><infon key="name_2">surname:Fugier-Vivier;given-names:I</infon><infon key="pub-id_doi">10.1016/S0952-7915(97)80145-8</infon><infon key="section_type">REF</infon><infon key="source">Curr Opinion Immunol</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1997</infon><offset>24437</offset><text>Mechanisms of selection and differentiation in germinal centers.</text></passage><passage><infon key="fpage">2075</infon><infon key="lpage">2085</infon><infon key="name_0">surname:Galibert;given-names:L</infon><infon key="name_1">surname:Burdin;given-names:N</infon><infon key="name_2">surname:Barth&#233;l&#233;my;given-names:C</infon><infon key="name_3">surname:Meffre;given-names:G</infon><infon key="name_4">surname:Durand;given-names:I</infon><infon key="name_5">surname:Garcia;given-names:E</infon><infon key="name_6">surname:Garrone;given-names:P</infon><infon key="name_7">surname:Rousset;given-names:F</infon><infon key="name_8">surname:Banchereau;given-names:J</infon><infon key="name_9">surname:Liu;given-names:YJ</infon><infon key="pub-id_pmid">8642318</infon><infon key="section_type">REF</infon><infon key="source">J Exp Med</infon><infon key="type">ref</infon><infon key="volume">183</infon><infon key="year">1996</infon><offset>24502</offset><text>Negative selection of human germinal center B cells by prolonged BCR cross-linking.</text></passage><passage><infon key="fpage">238</infon><infon key="lpage">239</infon><infon key="name_0">surname:Liu;given-names:YJ</infon><infon key="pub-id_doi">10.1126/science.278.5336.238</infon><infon key="pub-id_pmid">9340771</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">278</infon><infon key="year">1997</infon><offset>24586</offset><text>Reuse of B lymphocytes in germinal centers.</text></passage><passage><infon key="fpage">334</infon><infon key="lpage">338</infon><infon key="name_0">surname:Shokat;given-names:KM</infon><infon key="name_1">surname:Goodnow;given-names:CC</infon><infon key="pub-id_doi">10.1038/375334a0</infon><infon key="pub-id_pmid">7753200</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">375</infon><infon key="year">1995</infon><offset>24630</offset><text>Antigen-induced B-cell death and elimination during germinal-centre immune responses.</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">334</infon><infon key="name_0">surname:Pulendran;given-names:B</infon><infon key="name_1">surname:Kannourakis;given-names:G</infon><infon key="name_2">surname:Nouri;given-names:S</infon><infon key="name_3">surname:Smith;given-names:KGC</infon><infon key="name_4">surname:Nossal;given-names:GJV</infon><infon key="pub-id_doi">10.1038/375331a0</infon><infon key="pub-id_pmid">7753199</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">375</infon><infon key="year">1995</infon><offset>24716</offset><text>Soluble antigen can cause enhanced apoptosis of germinal-center B cells.</text></passage><passage><infon key="fpage">1830</infon><infon key="lpage">1837</infon><infon key="name_0">surname:Gulbranson-Judge;given-names:A</infon><infon key="name_1">surname:MacLennan;given-names:ICM</infon><infon key="pub-id_pmid">8765028</infon><infon key="section_type">REF</infon><infon key="source">Eur J Immunol</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1996</infon><offset>24789</offset><text>Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c.</text></passage><passage><infon key="fpage">263</infon><infon key="lpage">266</infon><infon key="name_0">surname:Zheng;given-names:B</infon><infon key="name_1">surname:Han;given-names:S</infon><infon key="name_2">surname:Zhu;given-names:Q</infon><infon key="name_3">surname:Goldsby;given-names:R</infon><infon key="name_4">surname:Kelsoe;given-names:G</infon><infon key="pub-id_doi">10.1038/384263a0</infon><infon key="pub-id_pmid">8918876</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">384</infon><infon key="year">1996</infon><offset>24900</offset><text>Alternative pathways for the selection of antigen-specific peripheral T cells.</text></passage><passage><infon key="fpage">278</infon><infon key="lpage">282</infon><infon key="name_0">surname:Westermann;given-names:J</infon><infon key="name_1">surname:Pabst;given-names:R</infon><infon key="pub-id_doi">10.1016/0167-5699(96)80545-7</infon><infon key="pub-id_pmid">8962631</infon><infon key="section_type">REF</infon><infon key="source">Immunol Today</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1996</infon><offset>24979</offset><text>How organ-specific is the migration of 'naive' and 'memory' T cells?.</text></passage><passage><infon key="fpage">143</infon><infon key="lpage">167</infon><infon key="name_0">surname:Swain;given-names:SL</infon><infon key="name_1">surname:Croft;given-names:M</infon><infon key="name_2">surname:Dubey;given-names:C</infon><infon key="name_3">surname:Haynes;given-names:L</infon><infon key="name_4">surname:Rogers;given-names:P</infon><infon key="name_5">surname:Zhang;given-names:X</infon><infon key="name_6">surname:Bradley;given-names:LM</infon><infon key="pub-id_pmid">8782706</infon><infon key="section_type">REF</infon><infon key="source">Immunol Rev</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">1996</infon><offset>25049</offset><text>From naive to memory T cells.</text></passage><passage><infon key="fpage">60</infon><infon key="lpage">64</infon><infon key="name_0">surname:Bell;given-names:EB</infon><infon key="name_1">surname:Sparshott;given-names:SM</infon><infon key="name_2">surname:Bunce;given-names:C</infon><infon key="pub-id_doi">10.1016/S0167-5699(97)01211-5</infon><infon key="pub-id_pmid">9509759</infon><infon key="section_type">REF</infon><infon key="source">Immunol Today</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1998</infon><offset>25079</offset><text>CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept.</text></passage><passage><infon key="fpage">361</infon><infon key="lpage">369</infon><infon key="name_0">surname:Shaw;given-names:AS</infon><infon key="name_1">surname:Dustin;given-names:ML</infon><infon key="pub-id_pmid">9133415</infon><infon key="section_type">REF</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1997</infon><offset>25166</offset><text>Making the T cell receptor go the distance: a topological view of T cell activation.</text></passage><passage><infon key="fpage">1621</infon><infon key="lpage">1637</infon><infon key="name_0">surname:Cebri&#225;n;given-names:M</infon><infon key="name_1">surname:Yag&#252;e;given-names:E</infon><infon key="name_2">surname:Rinc&#243;n;given-names:M</infon><infon key="name_3">surname:L&#243;pez-Botet;given-names:M</infon><infon key="name_4">surname:de Land&#225;zuri;given-names:MO</infon><infon key="name_5">surname:S&#225;nchez-Madrid;given-names:F</infon><infon key="pub-id_pmid">2903209</infon><infon key="section_type">REF</infon><infon key="source">J Exp Med</infon><infon key="type">ref</infon><infon key="volume">168</infon><infon key="year">1988</infon><offset>25251</offset><text>Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.</text></passage><passage><infon key="fpage">1854</infon><infon key="lpage">1860</infon><infon key="name_0">surname:Testi;given-names:R</infon><infon key="name_1">surname:Phillips;given-names:JH</infon><infon key="name_2">surname:Lanier;given-names:LL</infon><infon key="pub-id_pmid">2466079</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">142</infon><infon key="year">1989</infon><offset>25372</offset><text>Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering.</text></passage><passage><infon key="fpage">127</infon><infon key="lpage">136</infon><infon key="name_0">surname:Kosco-Vilbois;given-names:MH</infon><infon key="name_1">surname:Bonnefoy;given-names:JY</infon><infon key="name_2">surname:Chvatchko;given-names:Y</infon><infon key="pub-id_pmid">9176704</infon><infon key="section_type">REF</infon><infon key="source">Immunol Rev</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="year">1997</infon><offset>25462</offset><text>The physiology of murine germinal center reactions.</text></passage><passage><infon key="fpage">511</infon><infon key="lpage">514</infon><infon key="name_0">surname:Camacho;given-names:SA</infon><infon key="name_1">surname:Kosco-Vilbois;given-names:MH</infon><infon key="name_2">surname:Berek;given-names:C</infon><infon key="pub-id_doi">10.1016/S0167-5699(98)01327-9</infon><infon key="pub-id_pmid">9818545</infon><infon key="section_type">REF</infon><infon key="source">Immunol Today</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1998</infon><offset>25514</offset><text>The dynamic structure of the germinal center.</text></passage><passage><infon key="fpage">4865</infon><infon key="lpage">4875</infon><infon key="name_0">surname:Young;given-names:AJ</infon><infon key="name_1">surname:Marston;given-names:WL</infon><infon key="name_2">surname:Dessing;given-names:M</infon><infon key="name_3">surname:Dudler;given-names:L</infon><infon key="name_4">surname:Hein;given-names:WR</infon><infon key="pub-id_pmid">9389703</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">1997</infon><offset>25560</offset><text>Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by the coordinated expression of CD21 and L-selectin.</text></passage><passage><infon key="fpage">239</infon><infon key="lpage">248</infon><infon key="name_0">surname:Liu;given-names:YJ</infon><infon key="name_1">surname:Barth&#233;l&#233;my;given-names:C</infon><infon key="name_2">surname:de Bouteiller;given-names:O</infon><infon key="name_3">surname:Arpin;given-names:C</infon><infon key="name_4">surname:Durand;given-names:I</infon><infon key="name_5">surname:Banchereau;given-names:J</infon><infon key="pub-id_pmid">7535180</infon><infon key="section_type">REF</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1995</infon><offset>25714</offset><text>Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-l and B7-2.</text></passage><passage><infon key="fpage">96</infon><infon key="lpage">99</infon><infon key="name_0">surname:Garside;given-names:P</infon><infon key="name_1">surname:Ingulli;given-names:E</infon><infon key="name_2">surname:Merica;given-names:RR</infon><infon key="name_3">surname:Jonhson;given-names:JG</infon><infon key="name_4">surname:Noelle;given-names:RJ</infon><infon key="name_5">surname:Jenkins;given-names:MK</infon><infon key="pub-id_doi">10.1126/science.281.5373.96</infon><infon key="pub-id_pmid">9651253</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">281</infon><infon key="year">1998</infon><offset>25857</offset><text>Visualization of specific B and T lymphocyte interactions in the lymph node.</text></passage></document></collection>